You are here:
NICE
NICE Guidance
Conditions and diseases
Cancer
Breast cancer
Denosumab for the prevention of skeletal-related events in adults with bone metastases from solid tumours
Technology appraisal guidance
Reference number:
TA265
Published:
24 October 2012
Guidance
Tools and resources
Information for the public
History
Download guidance (PDF)
Overview
1 Guidance
2 Clinical need and practice
3 The technology
4 Evidence and interpretation
5 Implementation
6 Related NICE guidance
7 Review of guidance
Appendix A: Appraisal Committee members and NICE project team
Appendix B: Sources of evidence considered by the Committee
Changes after publication
About this guidance
Changes after publication
February 2014:
mi
nor maintenance
Next page
About this guidance
Previous page
Appendix B: Sources of evidence considered by the Committee